The 2021-2022 position of brazilian diabetes society on diabetic kidney disease (dkd) management: an evidence-based guideline to clinical practice. screening and treatment of hyperglycemia, arterial hypertension, and dyslipidemia in the patient with dkd

HIGHLIGHTS

• who: Jou00e3o Roberto de Su00e1 from the Barcelos, Pru00e9dio, u00ba andar, Porto Alegre, RS, Brazil have published the research work: The 2021-2022 position of Brazilian Diabetes Society on diabetic kidney disease (DKD) management: an evidence-based guideline to clinical practice. Screening and treatment of hyperglycemia, arterial hypertension, and dyslipidemia in the patient with DKD, in the Journal: (JOURNAL)
• what: It is important to emphasize that the studies were not designed to assess the renal effects, with albuminuria being a secondary outcome.
• future: The ADVANCE ON trial was a six-year observational extension . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.